<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05105477</url>
  </required_header>
  <id_info>
    <org_study_id>2021-04</org_study_id>
    <nct_id>NCT05105477</nct_id>
  </id_info>
  <brief_title>HPI SMART-BP Trial</brief_title>
  <official_title>Hypotension Prediction Index (HPI) Software Guided Hemodynamic Management for Noncardiac Surgery Patients - Blood Pressure Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Edwards Lifesciences</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Edwards Lifesciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      A multicenter, randomized comparison of intraoperative hemodynamic management with or without&#xD;
      a protocolized strategy utilizing Hypotension Prediction Index (HPI) software guidance during&#xD;
      moderate-to-high-risk noncardiac surgery.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 30, 2021</start_date>
  <completion_date type="Anticipated">May 2, 2025</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>A composite of 30-day moderate-to-severe perfusion related postoperative complications.</measure>
    <time_frame>From post non-cardiac surgery to 30 days.</time_frame>
    <description>A composite of 30-day moderate-to-severe perfusion related postoperative complications.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1486</enrollment>
  <condition>Moderate to High-risk Noncardiac Surgery</condition>
  <arm_group>
    <arm_group_label>HPI Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>AcumenTM HPI Software Feature to guide hemodynamic management in moderate-to-high-risk noncardiac surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-HPI arm</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Non-protocolized standard of care management per clinician and provider judgement</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AcumenTM HPI Software Feature</intervention_name>
    <description>The AcumenTM HPI Feature Software provides the clinician with physiological insight into a patient's likelihood of trending toward a hypotensive event. The AcumenTM HPI Feature Software suite is enabled by the minimally invasive Acumen IQ sensor.</description>
    <arm_group_label>HPI Arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Non-protocolized Standard of Care</intervention_name>
    <description>Non-protocolized standard of care to treat subjects</description>
    <arm_group_label>Non-HPI arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Signed informed consent&#xD;
&#xD;
          2. Age &gt;18 years&#xD;
&#xD;
          3. ASA Physical Status &gt; 2&#xD;
&#xD;
          4. Noncardiac surgery with expected surgery duration &gt; 2 hours (example include:&#xD;
             orthopedic, spine, urology, and general surgery)&#xD;
&#xD;
          5. Planned blood pressure monitoring with an arterial line catheter;&#xD;
&#xD;
          6. General anesthesia;&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Participating in another interventional Trial;&#xD;
&#xD;
          2. Contraindication to arterial blood pressure monitoring;&#xD;
&#xD;
          3. Subjects with a physical site area too limited for proper Sensor placement&#xD;
&#xD;
          4. Serum creatine &gt; 175 Î¼mol/L (&gt;2.0 mg/dL) or CKD stage &gt; 3A&#xD;
&#xD;
          5. Scheduled for intracranial surgery with permissive hypotension;&#xD;
&#xD;
          6. Patient who is confirmed to be pregnant and/or nursing mothers;&#xD;
&#xD;
          7. Patients with an intra-aortic balloon pump (IABP) or ventricular assist device(s);&#xD;
&#xD;
          8. Have a condition that precludes routine or tight blood pressure management such as&#xD;
             surgeon request for relative hypotension;&#xD;
&#xD;
          9. Emergency surgery;&#xD;
&#xD;
         10. Require beach-chair positioning;&#xD;
&#xD;
         11. Scheduled for cardiac surgeries&#xD;
&#xD;
         12. Have previously participated in the SMART-BP trial.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Kathy Akagha</last_name>
    <phone>(949) 250-7169</phone>
    <email>kathy_akagha@edwards.com</email>
  </overall_contact>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 22, 2021</study_first_submitted>
  <study_first_submitted_qc>October 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 3, 2021</study_first_posted>
  <last_update_submitted>October 22, 2021</last_update_submitted>
  <last_update_submitted_qc>October 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

